Department of Intensive Care Unit, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Neurosurgery, Affiliated Hospital 2 of Nantong University and First People's Hospital of Nantong City, Nantong, China.
Front Immunol. 2022 Sep 6;13:975695. doi: 10.3389/fimmu.2022.975695. eCollection 2022.
BACKGROUND: Central nervous system tumor (CNST) is one of the most complicated and lethal forms of human tumors with very limited treatment options. In recent years, growing evidence indicates that oncolytic virotherapy (OVT) has emerged as a promising therapeutic strategy for CNSTs. And a considerable amount of literature on OVT-CNSTs has been published. However, there are still no studies summarizing the global research trends and hotspots of this field through a bibliometric approach. To fulfill this knowledge gap, bibliometric analysis was conducted based on all publications relating to OVT-CNSTs since 2000s. METHODS: We searched the Web of Science Core Collection for all relevant studies published between 2000 and 2022. Four different tools (online analysis platform, R-bibliometrix, CiteSpace and VOSviewer) were used to perform bibliometric analysis and network visualization, including annual publication output, active journals, contribution of countries, institutions, and authors, references, as well as keywords. RESULTS: A total of 473 articles and reviews were included. The annual number of publications on OVT-CNSTs showed a significant increasing trend. and were the most active and co-cited journals, respectively. In terms of contributions, there is no doubt that the United States occupied a leading position with the most publications (n=307, 64.9%) and the highest H-index (57). The institution and author that contributed the largest number of publications were Ohio State University and Chiocca EA, respectively. As can be seen from citation analysis, the current studies mainly focused on preclinical and phase I/II clinical results of various oncolytic virus for CNSTs treatment. Keywords co-occurrence and burst analysis revealed that the following research topics including immunotherapy, T-cells, tumor microenvironment, vaccine, blood-brain-barrier, checkpoint inhibitors, macrophage, stem cell, and recurrent glioblastoma have been research frontiers of this field and also have great potential to continue to be research hotspots in the future. CONCLUSION: There has been increasing attention on oncolytic viruses for use as CNSTs therapeutics. Oncolytic immunotherapy is a topic of great concern in this field. This bibliometric study provides a comprehensive analysis of the knowledge base, research hotspots, development perspective in the field of OVT-CNSTs, which could become an essential reference for scholars in this area.
背景:中枢神经系统肿瘤(CNST)是人类肿瘤中最复杂和最致命的形式之一,治疗选择非常有限。近年来,越来越多的证据表明,溶瘤病毒治疗(OVT)已成为治疗 CNST 的一种很有前途的治疗策略。并且已经发表了相当数量的关于 OVT-CNST 的文献。然而,仍然没有研究通过文献计量学方法来总结该领域的全球研究趋势和热点。为了填补这一知识空白,对 2000 年代以来所有与 OVT-CNST 相关的出版物进行了文献计量学分析。 方法:我们在 Web of Science 核心合集上搜索了 2000 年至 2022 年期间发表的所有相关研究。使用四个不同的工具(在线分析平台、R-bibliometrix、CiteSpace 和 Vosviewer)进行文献计量分析和网络可视化,包括年度出版物输出、活跃期刊、国家、机构和作者的贡献、参考文献以及关键词。 结果:共纳入 473 篇文章和综述。OVT-CNST 的年度出版物数量呈显著增长趋势。和 分别是最活跃和被引频次最高的期刊。就贡献而言,美国无疑占据主导地位,发表的论文数量最多(n=307,64.9%),H 指数最高(57)。贡献最多出版物的机构和作者分别是俄亥俄州立大学和 Chiocca EA。从引文分析可以看出,目前的研究主要集中在各种溶瘤病毒治疗 CNST 的临床前和 I/II 期结果。关键词共现和突发分析表明,免疫疗法、T 细胞、肿瘤微环境、疫苗、血脑屏障、检查点抑制剂、巨噬细胞、干细胞和复发性胶质母细胞瘤等研究主题是该领域的研究前沿,并且未来也有很大的潜力成为研究热点。 结论:人们对溶瘤病毒作为 CNST 治疗药物的应用越来越关注。溶瘤免疫治疗是该领域关注的一个重要课题。这项文献计量研究对 OVT-CNST 领域的知识库、研究热点和发展前景进行了全面分析,可为该领域的学者提供重要参考。
Medicine (Baltimore). 2019-8
Front Endocrinol (Lausanne). 2023
Front Immunol. 2023
Front Biosci (Landmark Ed). 2022-8-31
Front Med (Lausanne). 2025-5-9
Drug Des Devel Ther. 2025-5-20
J Cancer Surviv. 2025-4-5
J Assist Reprod Genet. 2025-4
Front Pharmacol. 2022-6-16
Pharmacol Ther. 2022-11
World Neurosurg. 2022-5